Novocure Ltd. | Ownership
Companies that own Novocure Ltd.
Fidelity Management & Research Co.
7,849,721
8.44%
881,776
0.04%
06/30/2018
The Vanguard Group, Inc.
4,816,864
5.19%
83,220
0.01%
06/30/2018
BlackRock Fund Advisors
4,171,178
4.49%
717,626
0.01%
06/30/2018
Baillie Gifford & Co.
3,093,395
3.33%
343,756
0.09%
06/30/2018
Capital Research & Management Co. (World Investors)
1,878,711
2.02%
1,878,711
0.01%
06/30/2018
Farallon Capital Management LLC
1,590,000
1.71%
-260,000
0.47%
06/30/2018
TimesSquare Capital Management LLC
1,485,900
1.6%
1,485,900
0.38%
06/30/2018
SSgA Funds Management, Inc.
1,321,727
1.42%
211,513
0%
06/30/2018
Waddell & Reed Investment Management Co.
1,270,789
1.37%
-35,300
0.1%
06/30/2018
Tamarack Advisers LP
1,100,000
1.18%
-15,000
14.6%
06/30/2018
| Address |
No. 4 The Forum
St. Helier Jersey JE2 4UF
United Kingdom
|
|
Employees
|
- |
| Website |
http://www.novocure.com |
| Updated |
07/08/2019 |
| Novocure Ltd. operates as an oncology company. It enages in developing its propriety technoclogy, Tumor Treating Fields, which uses electric fields tuned to specific frequencies to disrupt cancer cell division, inhibiting tumor growth, and causing affected cancer cells to die. The company was founded by Yoram Palti in 2000 and is headquartered in St. |
